Chen M, Joshi KC, Kolb B et al. J Neurointerv Surg. 2024 Mar 12:jnis-2023-021219. doi: 10.1136/jnis-2023-021219. Online ahead of print. PMID: 38471760
Publicaciones
Time of the day and season distribution among stroke code subtypes: differences between ischemic stroke, intracranial hemorrhage, and stroke mimic
Menéndez Albarracín A, Valls Carbó A, Rabaneda Lombarte N et al. Front Neurol. 2024 Mar 26;15:1372324. doi: 10.3389/fneur.2024.1372324. eCollection 2024. PMID: 38595853
The Role of Epigenetics in Brain Aneurysm and Subarachnoid Hemorrhage: A Comprehensive Review
Fernández-Pérez I, Macias-Gómez A, Suárez-Pérez A et al. Int J Mol Sci. 2024 Mar 19;25(6):3433. doi: 10.3390/ijms25063433. PMID: 38542406
https://pubmed.ncbi.nlm.nih.gov/38542406/
Abstract: This comprehensive review explores the emerging field of epigenetics in intracranial aneurysm (IA) and aneurysmal subarachnoid hemorrhage (aSAH). Despite recent advancements, the high mortality of aSAH needs an understanding of its underlying pathophysiology, where epigenetics plays a crucial role. This review synthesizes the current knowledge, focusing on three primary epigenetic mechanisms: DNA methylation, non-coding RNA (ncRNA), and histone modification in IA and aSAH. While DNA methylation studies are relatively limited, they suggest a significant role in the pathogenesis and prognosis of IA and aSAH, highlighting differentially methylated positions in genes presumably involved in these pathologies. However, methodological limitations, including small sample sizes and a lack of diverse population studies, temper these results. The role of
ncRNAs, particularly miRNAs, has been more extensively studied, but there are still few studies focused on histone modifications. Despite methodological challenges and inconsistent findings, these studies underscore the involvement of miRNAs in key pathophysiological processes, including vascular smooth muscle regulation and the inflammatory response. This review emphasizes methodological challenges in epigenetic research, advocating for large-scale epigenome-wide associationnstudies integrating genetic and environmental factors, along with longitudinal studies. Such research could unravel the complex mechanisms behind IA and aSAH, guiding the development of targeted therapeutic approaches.
Funding: This research was supported in part by Spain’s Ministry of Health (Instituto de Salud Carlos III, Fondos FEDER, (RICORS-ICTUS/RD21/0006/0021)).
Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies
Olmo ED, Barboza B, Delgado-Esteban M et al. Bioorg Chem. 2024 Mar 3;146:107255. doi: 10.1016/j.bioorg.2024.107255. Online ahead of print. PMID: 38457955
Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke
Correa-Paz C, Pérez-Mato M, Bellemain-Sagnard M et al. J Cereb Blood Flow Metab. 2024 Mar 4:271678X241237427. doi: 10.1177/0271678X241237427. Online ahead of print. PMID: 38436292
Pilot Study Assessing the Safety and Acceptance of a Novel Virtual Reality System to Improve Visual Function
Leal-Vega L, Piñero DP, Molina-Martín A et al. Semin Ophthalmol. 2024 Mar 1:1-6. doi: 10.1080/08820538.2024.2324074. Online ahead of print. PMID: 38426308
Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial
Marchina S, Yeatts SD, Foster LD et al. Cerebrovasc Dis. 2025;54(2):270-277. doi: 10.1159/000538195. Epub 2024 Mar 16. PMID: 38493765
Endothelial cells and macrophages as allies in the healthy and diseased brain
Denes A, Hansen CE, Oezorhan U et al. Acta Neuropathol. 2024 Feb 12;147(1):38. doi: 10.1007/s00401-024-02695-0. PMID: 38347307
Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients With Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial
Sarraj A, Hill MD, Hussain MS, Abraham MG et al. JAMA Neurol. 2024 Feb 8:e240206. doi: 10.1001/jamaneurol.2024.0206. Online ahead of print. PMID: 38363872
Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial
Mazighi M, Köhrmann M, Lemmens R et al. Lancet Neurol. 2024 Feb;23(2):157-167. doi: 10.1016/S1474-4422(23)00427-1. PMID: 38267188

